Artykuły w czasopismach na temat „Latent membrane protein one”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Latent membrane protein one”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Zhang, Yujiao, Yinzhong Shen, Lin Yin, et al. "Plasma Membrane Proteomic Profile Discovers Macrophage-capping Protein Related to Latent HIV-1." Current HIV Research 17, no. 1 (2019): 42–52. http://dx.doi.org/10.2174/1570162x17666190506155222.
Pełny tekst źródłaDiduk, S. V., K. V. Smirnova, and V. E. Gurtsevitch. "THE INFLUENCE OF POINT MUTATIONS IN THE EPSTEIN-BARR VIRUS LMP1 ONCOGENE ON THE CELL CYTOSKELETON AND ACTIVATION OF INDUCIBLE FORM OF NO SYNTHASE." Annals of the Russian academy of medical sciences 67, no. 3 (2012): 62–67. http://dx.doi.org/10.15690/vramn.v67i3.187.
Pełny tekst źródłaMurray, R. J., M. G. Kurilla, J. M. Brooks, et al. "Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies." Journal of Experimental Medicine 176, no. 1 (1992): 157–68. http://dx.doi.org/10.1084/jem.176.1.157.
Pełny tekst źródłaLiebowitz, D., R. Kopan, E. Fuchs, J. Sample, and E. Kieff. "An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes." Molecular and Cellular Biology 7, no. 7 (1987): 2299–308. http://dx.doi.org/10.1128/mcb.7.7.2299-2308.1987.
Pełny tekst źródłaLiebowitz, D., R. Kopan, E. Fuchs, J. Sample, and E. Kieff. "An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes." Molecular and Cellular Biology 7, no. 7 (1987): 2299–308. http://dx.doi.org/10.1128/mcb.7.7.2299.
Pełny tekst źródłaEngels, Niklas, Mark Merchant, Rajita Pappu, Andrew C. Chan, Richard Longnecker, and Jürgen Wienands. "Epstein-Barr Virus Latent Membrane Protein 2a (Lmp2a) Employs the Slp-65 Signaling Module." Journal of Experimental Medicine 194, no. 3 (2001): 255–64. http://dx.doi.org/10.1084/jem.194.3.255.
Pełny tekst źródłaKaykas, Ajamete, Kathleen Worringer, and Bill Sugden. "LMP-1's Transmembrane Domains Encode Multiple Functions Required for LMP-1's Efficient Signaling." Journal of Virology 76, no. 22 (2002): 11551–60. http://dx.doi.org/10.1128/jvi.76.22.11551-11560.2002.
Pełny tekst źródłaLee, Song Hee, Katie Caviness, Emily R. Albright, et al. "Long and Short Isoforms of the Human Cytomegalovirus UL138 Protein Silence IE Transcription and Promote Latency." Journal of Virology 90, no. 20 (2016): 9483–94. http://dx.doi.org/10.1128/jvi.01547-16.
Pełny tekst źródłaMoskalev, Alexander V., Boris Yu Gumilevsky, Vasiliy Ya Apchel, and Vasiliy N. Tsygan. "The role of viruses in cell transformation and oncogenesis." Bulletin of the Russian Military Medical Academy 25, no. 1 (2023): 133–44. http://dx.doi.org/10.17816/brmma121327.
Pełny tekst źródłaDudziak, Diana, Arnd Kieser, Ulrike Dirmeier та ін. "Latent Membrane Protein 1 of Epstein-Barr Virus Induces CD83 by the NF-κB Signaling Pathway". Journal of Virology 77, № 15 (2003): 8290–98. http://dx.doi.org/10.1128/jvi.77.15.8290-8298.2003.
Pełny tekst źródłaMurthy, M. S., and S. V. Pande. "Some differences in the properties of carnitine palmitoyltransferase activities of the mitochondrial outer and inner membranes." Biochemical Journal 248, no. 3 (1987): 727–33. http://dx.doi.org/10.1042/bj2480727.
Pełny tekst źródłaTang, Xiaoli, Huafei Lu, Patrick M. Tarwater, David L. Silverberg, Christoph Schorl та Bharat Ramratnam. "Adeno-Associated Virus (AAV)-Delivered Exosomal TAT and BiTE Molecule CD4-αCD3 Facilitate the Elimination of CD4 T Cells Harboring Latent HIV-1". Microorganisms 12, № 8 (2024): 1707. http://dx.doi.org/10.3390/microorganisms12081707.
Pełny tekst źródłaBabinska, Anna, Michael V. Hogan, Tomasz Sobocki, Malgorzata B. Sobocka, Yigal H. Ehrlich, and Elizabeth Kornecki. "Identification of ecto-PKC on surface of human platelets: role in maintenance of latent fibrinogen receptors." American Journal of Physiology-Heart and Circulatory Physiology 278, no. 6 (2000): H2008—H2019. http://dx.doi.org/10.1152/ajpheart.2000.278.6.h2008.
Pełny tekst źródłaSato, Hitoshi, Lesley Pesnicak, and Jeffrey I. Cohen. "Varicella-Zoster Virus Open Reading Frame 2 Encodes a Membrane Phosphoprotein That Is Dispensable for Viral Replication and for Establishment of Latency." Journal of Virology 76, no. 7 (2002): 3575–78. http://dx.doi.org/10.1128/jvi.76.7.3575-3578.2002.
Pełny tekst źródłaEndo, K., S. Kondo, J. Shackleford, et al. "Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration." Oncogene 28, no. 14 (2009): 1725–35. http://dx.doi.org/10.1038/onc.2009.20.
Pełny tekst źródłaFotheringham, J. A., S. Mazzucca та N. Raab-Traub. "Epstein-Barr virus latent membrane protein-2A-induced ΔNp63α expression is associated with impaired epithelial-cell differentiation". Oncogene 29, № 30 (2010): 4287–96. http://dx.doi.org/10.1038/onc.2010.175.
Pełny tekst źródłaPollock, A. M., M. Toner, M. McMenamin, J. Walker, and C. I. Timon. "Absence of Epstein-Barr virus encoded RNA and latent membrane protein (LMP1) in salivary gland neoplasms." Journal of Laryngology & Otology 113, no. 10 (1999): 906–8. http://dx.doi.org/10.1017/s0022215100145542.
Pełny tekst źródłaPrince, Stuart, Sinead Keating, Ceri Fielding, Paul Brennan, Eike Floettmann, and Martin Rowe. "Latent Membrane Protein 1 Inhibits Epstein-Barr Virus Lytic Cycle Induction and Progress via Different Mechanisms." Journal of Virology 77, no. 8 (2003): 5000–5007. http://dx.doi.org/10.1128/jvi.77.8.5000-5007.2003.
Pełny tekst źródłaRepic, Allison M., Mingxia Shi, Rona S. Scott, and John W. Sixbey. "Augmented Latent Membrane Protein 1 Expression from Epstein-Barr Virus Episomes with Minimal Terminal Repeats." Journal of Virology 84, no. 5 (2009): 2236–44. http://dx.doi.org/10.1128/jvi.01972-09.
Pełny tekst źródłaBurton, Eric M., Davide Maestri, Shaowen White, et al. "Epstein-Barr virus latent membrane protein 1 subverts IMPDH pathways to drive B-cell oncometabolism." PLOS Pathogens 21, no. 5 (2025): e1013092. https://doi.org/10.1371/journal.ppat.1013092.
Pełny tekst źródłaTaniere, P., A. Manai, R. Charpentier, et al. "Pyothorax-associated lymphoma: relationship with Epstein-Barr virus, human herpes virus-8 and body cavity-based high grade lymphomas." European Respiratory Journal 11, no. 3 (1998): 779–83. http://dx.doi.org/10.1183/09031936.98.11030779.
Pełny tekst źródłaKusano, Shuichi, and Nancy Raab-Traub. "An Epstein-Barr Virus Protein Interacts with Notch." Journal of Virology 75, no. 1 (2001): 384–95. http://dx.doi.org/10.1128/jvi.75.1.384-395.2001.
Pełny tekst źródłaSwanson-Mungerson, Michelle, Rebecca Bultema, and Richard Longnecker. "Epstein-Barr Virus Latent Membrane Protein 2A protects B cells from MYC-induced apoptosis and accelerates tumor development (45.14)." Journal of Immunology 182, no. 1_Supplement (2009): 45.14. http://dx.doi.org/10.4049/jimmunol.182.supp.45.14.
Pełny tekst źródłaSwanson-Mungerson, Michelle A., Robert G. Caldwell, Rebecca Bultema, and Richard Longnecker. "Epstein-Barr Virus LMP2A Alters In Vivo and In Vitro Models of B-Cell Anergy, but Not Deletion, in Response to Autoantigen." Journal of Virology 79, no. 12 (2005): 7355–62. http://dx.doi.org/10.1128/jvi.79.12.7355-7362.2005.
Pełny tekst źródłaŠimičić, Petra, Margarita Batović, Anita Stojanović Marković, and Snjezana Židovec-Lepej. "Deciphering the Role of Epstein–Barr Virus Latent Membrane Protein 1 in Immune Modulation: A Multifaced Signalling Perspective." Viruses 16, no. 4 (2024): 564. http://dx.doi.org/10.3390/v16040564.
Pełny tekst źródłaZhang, Jun, Subash C. Das, Catherine Kotalik, Asit K. Pattnaik, and Luwen Zhang. "The Latent Membrane Protein 1 of Epstein-Barr Virus Establishes an Antiviral State via Induction of Interferon-stimulated Genes." Journal of Biological Chemistry 279, no. 44 (2004): 46335–42. http://dx.doi.org/10.1074/jbc.m403966200.
Pełny tekst źródłaAlexander, D. R., J. M. Hexham, and M. J. Crumpton. "The association of type 1, type 2A and type 2B phosphatases with the human T lymphocyte plasma membrane." Biochemical Journal 256, no. 3 (1988): 885–92. http://dx.doi.org/10.1042/bj2560885.
Pełny tekst źródłaIncrocci, Ryan, Rosalinda Monroy Del Toro, Grace Devitt, Melody Salimian, Kamaljit Braich та Michelle Swanson-Mungerson. "Epstein–Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mTOR and HIF-1α". International Journal of Molecular Sciences 25, № 7 (2024): 3944. http://dx.doi.org/10.3390/ijms25073944.
Pełny tekst źródłaPenkert, Rhiannon R., and Robert F. Kalejta. "Nuclear Localization of Tegument-Delivered pp71 in Human Cytomegalovirus-Infected Cells Is Facilitated by One or More Factors Present in Terminally Differentiated Fibroblasts." Journal of Virology 84, no. 19 (2010): 9853–63. http://dx.doi.org/10.1128/jvi.00500-10.
Pełny tekst źródłaAngrayany Sapar, Puput, Hamsu Kadriyan, and Didit Yudhanto. "Preliminary Study On Latent Membrane Protein-1 (LMP-1) And Bcl-2 Associated X (BAX) In Exosomes Of Patients With Nasopharingeal Cancer In NTB Provincial Hospital." KESANS : International Journal of Health and Science 1, no. 2 (2021): 117–30. http://dx.doi.org/10.54543/kesans.v1i2.9.
Pełny tekst źródłaPriti, Dipa Anesha, Ali Firoz, and Tiwari Abhishek. "Advances in Human Milk Fortification with Added Supplements." International Journal of Innovative Science and Research Technology 8, no. 1 (2023): 2467–75. https://doi.org/10.5281/zenodo.7677201.
Pełny tekst źródłaCaldwell, Robert G., R. Clark Brown та Richard Longnecker. "Epstein-Barr Virus LMP2A-Induced B-Cell Survival in Two Unique Classes of EμLMP2A Transgenic Mice". Journal of Virology 74, № 3 (2000): 1101–13. http://dx.doi.org/10.1128/jvi.74.3.1101-1113.2000.
Pełny tekst źródłaRedchenko, I. V., and A. B. Rickinson. "Accessing Epstein-Barr Virus-Specific T-Cell Memory with Peptide-Loaded Dendritic Cells." Journal of Virology 73, no. 1 (1999): 334–42. http://dx.doi.org/10.1128/jvi.73.1.334-342.1999.
Pełny tekst źródłaSwanson-Mungerson, Michelle, Ryan Incrocci, Molly McCormack, and Caroline Leof. "Effects of Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) on cytokine production in primary and transformed B cells (105.40)." Journal of Immunology 188, no. 1_Supplement (2012): 105.40. http://dx.doi.org/10.4049/jimmunol.188.supp.105.40.
Pełny tekst źródłaJoske, DJ, A. Emery-Goodman, E. Bachmann, F. Bachmann, B. Odermatt, and H. Knecht. "Epstein-Barr virus burden in Hodgkin's disease is related to latent membrane protein gene expression but not to active viral replication." Blood 80, no. 10 (1992): 2610–13. http://dx.doi.org/10.1182/blood.v80.10.2610.2610.
Pełny tekst źródłaJoske, DJ, A. Emery-Goodman, E. Bachmann, F. Bachmann, B. Odermatt, and H. Knecht. "Epstein-Barr virus burden in Hodgkin's disease is related to latent membrane protein gene expression but not to active viral replication." Blood 80, no. 10 (1992): 2610–13. http://dx.doi.org/10.1182/blood.v80.10.2610.bloodjournal80102610.
Pełny tekst źródłaSteinbrück, Lisa, Montse Gustems, Stephanie Medele, Thomas F. Schulz, Dominik Lutter, and Wolfgang Hammerschmidt. "K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus." Journal of Virology 89, no. 14 (2015): 7248–61. http://dx.doi.org/10.1128/jvi.00839-15.
Pełny tekst źródłaMansourizadeh, A., and K. Mansourizadeh. "Book Review Hollow Fiber Membrane Contactors: Module Fabrication, Design and Operation, and Potential Applications." Journal of Applied Membrane Science & Technology 27, no. 2 (2023): 115–23. http://dx.doi.org/10.11113/amst.v27n2.272.
Pełny tekst źródłaYang, C.-F., G.-D. Yang, T.-J. Huang, et al. "EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop." Oncogene 35, no. 26 (2015): 3419–31. http://dx.doi.org/10.1038/onc.2015.402.
Pełny tekst źródłaHay, David C., Graham D. Kemp, Catherine Dargemont та Ronald T. Hay. "Interaction between hnRNPA1 and IκBα Is Required for Maximal Activation of NF-κB-Dependent Transcription". Molecular and Cellular Biology 21, № 10 (2001): 3482–90. http://dx.doi.org/10.1128/mcb.21.10.3482-3490.2001.
Pełny tekst źródłaShibata, D., LM Weiss, AM Hernandez, BN Nathwani, L. Bernstein, and AM Levine. "Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus [see comments]." Blood 81, no. 8 (1993): 2102–9. http://dx.doi.org/10.1182/blood.v81.8.2102.2102.
Pełny tekst źródłaShibata, D., LM Weiss, AM Hernandez, BN Nathwani, L. Bernstein, and AM Levine. "Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus [see comments]." Blood 81, no. 8 (1993): 2102–9. http://dx.doi.org/10.1182/blood.v81.8.2102.bloodjournal8182102.
Pełny tekst źródłaBollard, Catherine M., Maja Stanojevic, Ann M. Leen, et al. "Complete Tumor Responses in Lymphoma Patients Who Receive Autologous Cytotoxic T Lymphocytes Targeting EBV Latent Membrane Proteins." Blood 112, no. 11 (2008): 230. http://dx.doi.org/10.1182/blood.v112.11.230.230.
Pełny tekst źródłaFaumont, Nathalie, Talal Al Saati, Pierre Brousset, Claudie Offer, Georges Delsol, and Fabienne Meggetto. "Demonstration by single-cell PCR that Reed–Sternberg cells and bystander B lymphocytes are infected by different Epstein–Barr virus strains in Hodgkin’s disease." Journal of General Virology 82, no. 5 (2001): 1169–74. http://dx.doi.org/10.1099/0022-1317-82-5-1169.
Pełny tekst źródłaCamilleri-Broet, S., F. Davi, J. Feuillard, et al. "High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas." Blood 86, no. 2 (1995): 432–35. http://dx.doi.org/10.1182/blood.v86.2.432.bloodjournal862432.
Pełny tekst źródłaPalefsky, Joel M., Jennifer Berline, Deborah Greenspan, and John S. Greenspan. "Evidence for trafficking of Epstein–Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes." Journal of General Virology 83, no. 2 (2002): 317–21. http://dx.doi.org/10.1099/0022-1317-83-2-317.
Pełny tekst źródłaSamir, Safia, Hend Okasha Ahmed, Tarek M. Diab, et al. "Rate of Epstein-Barr Virus in Gastric Adenocarcinoma in Egyptian Patients in View of the WHO Classification and Correlation with p16 Immunoreactivity." Open Access Macedonian Journal of Medical Sciences 10, A (2022): 1218–25. http://dx.doi.org/10.3889/oamjms.2022.9700.
Pełny tekst źródłaConacher, Margaret, Robin Callard, Karen McAulay, et al. "Epstein-Barr Virus Can Establish Infection in the Absence of a Classical Memory B-Cell Population." Journal of Virology 79, no. 17 (2005): 11128–34. http://dx.doi.org/10.1128/jvi.79.17.11128-11134.2005.
Pełny tekst źródłaAbdullah, Zahraa, Ahmed Abdulamir, and Faiq Gorial. "The Possible Role of Epstein Barr Virus and Its Latent Proteins in Systemic Lupus Erythematosus Patients." Iraqi Journal of Medical Sciences 18, no. 1 (2020): 4–11. http://dx.doi.org/10.22578/ijms.18.1.2.
Pełny tekst źródłaKelly, Gemma L., Julianna Stylianou, Andrew I. Bell, Wenbin Wei, Martin Rowe, and Alan B. Rickinson. "Three Restricted Forms of Epstein-Barr Virus Latency Counteracting Apoptosis in c-Myc Expressing Burkitt Lymphoma Cells." Blood 110, no. 11 (2007): 1572. http://dx.doi.org/10.1182/blood.v110.11.1572.1572.
Pełny tekst źródła